Pediatric Interventional Cardiology Market Growth And Forecast Report 2024-2033

The new report published by The Business Research Company, titled Pediatric Interventional Cardiology Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the pediatric interventional cardiology market size has grown strongly in recent years. It will grow from $2.31 billion in 2023 to $2.51 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The pediatric interventional cardiology market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10384&type=smp

Surge In Congenital Heart Disease Fuels The Growth Of The Pediatric Interventional Cardiology Market
The increasing prevalence of congenital heart disease is expected to propel the growth of the pediatric interventional cardiology market. Congenital heart disease is any problem that has affected the heart and its structure since birth. Pediatric interventional cardiology procedures are used to treat congenital heart disease that advantages over traditional open-heart surgery, including shorter recovery times, reduced risk of infection, and less scarring. For instance, in 2022, according to the American Heart Association, a US-based non-profit organization that is focused on cardiovascular medical research, approximately 40,000 infants in the United States are affected by congenital heart defects, and the birth prevalence of congenital heart diseases is estimated to be 12.3 per 1000 in the country. Furthermore, The Lancet, a weekly peer-reviewed general medical journal based in the United Kingdom, published an article in 2022 stating that congenital heart disease is the most common birth defect, affecting nearly 9 out of every 1000 live births. Therefore, the increasing prevalence of congenital heart disease will drive the growth of the pediatric interventional cardiology market.

Revolutionizing Pediatric Cardiology Market With Introduction Of Innovative Solutions
Product innovation is a key trend in the pediatric interventional cardiology market. Major companies in pediatric interventional cardiology are introducing new and innovative solutions to strengthen their position in the market. For instance, in February 2023, Medtronic plc., a US-based medical devices company launched a trans catheter pulmonary valve, the Harmony Transcatheter Pulmonary Valve System. The Harmony TPV system is a minimally invasive alternative to open-heart surgery and can be implanted through a small incision in the leg or neck. The Harmony TPV system is intended for patients who have previously undergone surgery for congenital heart disease and have a dysfunctional RVOT (right ventricular outflow tract) due to a previously implanted conduit or bio prosthetic pulmonary valve. It is also indicated for patients with native or patched RVOT who require pulmonary valve replacement.

The pediatric interventional cardiology market covered in this report is segmented -

1) By Device Type: Closure Devices, Trans catheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Other Device Types
2) By Procedure: Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Other Procedures
3) By End-Use: Clinical Testing Laboratories, Hospitals, Cardiac Centers, Pediatric Clinics, Research Institutions

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=10384&type=discount

Major companies operating in the pediatric interventional cardiology market report are Medtronic plc, GE HealthCare Technologies Inc., Abbott Laboratories, Cardinal Health Inc., Terumo Corporation, W.L. Gore & Associates Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Siemens Healthineers, Numed Inc., St. Jude Medical Inc., Cordis Corporation, Koninklijke Philips N.V., Biotronik, B. Braun Melsungen AG, Canon Medical Systems Corporation, Gore & Associates Inc., Johnson and Johnson, Cook Group LLC, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co.Ltd., Biosensors International Group Ltd., Cardiac Science Corporation, Asahi Intecc Co.Ltd., Medinol Ltd., Jotec GmbH, Hexacath Ltd., Translumina GmbH

Contents of the report:
1. Executive Summary
2. Pediatric Interventional Cardiology Market Report Structure
3. Pediatric Interventional Cardiology Market Trends And Strategies
4. Pediatric Interventional Cardiology Market - Macro Economic Scenario
5. Pediatric Interventional Cardiology Market Size And Growth
…..
27. Pediatric Interventional Cardiology Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/pediatric-interventional-cardiology-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.